Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 6:14 pm Purchase | 13G | Sage Therapeutics Inc. SAGE | BB BIOTECH AG | 4,460,693 7.300% | 955,693 (+27.27%) | View |
| 2024-11-12 4:56 pm Unchanged | 13G | Sage Therapeutics Inc. SAGE | VANGUARD GROUP INC | 5,760,449 9.430% | 0 (Unchanged) | View |
| 2024-11-12 10:34 am Sale | 13G | Sage Therapeutics Inc. SAGE | FMR LLC | 5,271,108 8.634% | -1,031,366 (-16.36%) | View |
| 2024-11-08 2:17 pm Unchanged | 13G | Sage Therapeutics Inc. SAGE | BlackRock Inc. | 5,390,913 8.800% | 0 (Unchanged) | View |
| 2024-11-04 3:28 pm Unchanged | 13G | Sage Therapeutics Inc. SAGE | VANGUARD GROUP INC | 5,760,449 9.430% | 0 (Unchanged) | View |
| 2024-11-04 2:10 pm Sale | 13G | Sage Therapeutics Inc. SAGE | VANGUARD GROUP INC | 5,760,449 9.430% | -542,098 (-8.60%) | View |
| 2024-10-21 4:11 pm Purchase | 13G | Sage Therapeutics Inc. SAGE | BlackRock Inc. | 5,390,913 8.800% | 5,390,913 (New Position) | View |
| 2024-10-18 11:37 am Sale | 13G | Sage Therapeutics Inc. SAGE | STATE STREET CORP STT | 2,926,239 4.800% | -991,983 (-25.32%) | View |
| 2024-06-10 12:15 pm Purchase | 13G | Sage Therapeutics Inc. SAGE | VANGUARD GROUP INC | 6,302,547 10.470% | 983,187 (+18.48%) | View |
| 2024-06-10 09:48 am Purchase | 13G | Sage Therapeutics Inc. SAGE | FMR LLC | 6,302,474 10.472% | 819,997 (+14.96%) | View |
| 2024-06-06 09:54 am Sale | 13G | Sage Therapeutics Inc. SAGE | WELLINGTON MANAGEMENT GROUP LLP | 39,757 0.070% | -6,022,239 (-99.34%) | View |
| 2024-02-14 07:09 am Purchase | 13G | Sage Therapeutics Inc. SAGE | RTW INVESTMENTS LP | 5,197,019 8.700% | 5,197,019 (New Position) | View |
| 2024-02-13 5:13 pm Purchase | 13G | Sage Therapeutics Inc. SAGE | VANGUARD GROUP INC | 5,319,360 8.860% | 433,808 (+8.88%) | View |
| 2024-02-13 06:28 am Purchase | 13G | Sage Therapeutics Inc. SAGE | BB BIOTECH AG | 3,505,000 5.800% | 404,722 (+13.05%) | View |
| 2024-02-09 09:49 am Sale | 13G | Sage Therapeutics Inc. SAGE | FMR LLC | 5,482,477 9.132% | -1,069,013 (-16.32%) | View |
| 2024-02-08 10:17 am Sale | 13G | Sage Therapeutics Inc. SAGE | WELLINGTON MANAGEMENT GROUP LLP | 6,061,996 10.100% | -301,634 (-4.74%) | View |
| 2024-01-26 11:49 am Sale | 13G | Sage Therapeutics Inc. SAGE | BlackRock Inc. BLK | 4,663,900 7.800% | -246,242 (-5.01%) | View |
| 2024-01-24 10:04 am Purchase | 13G | Sage Therapeutics Inc. SAGE | STATE STREET CORP STT | 3,918,222 6.530% | 3,918,222 (New Position) | View |
| 2023-07-10 08:44 am Purchase | 13G | Sage Therapeutics Inc. SAGE | WELLINGTON MANAGEMENT GROUP LLP | 6,363,630 10.650% | 847,494 (+15.36%) | View |
| 2023-02-17 5:23 pm Purchase | 13G | Sage Therapeutics Inc. SAGE | BB BIOTECH AG | 3,100,278 5.200% | 150,000 (+5.08%) | View |